Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.
Splicing factor gene mutations are the most frequent mutations found in patients with the myeloid malignancy myelodysplastic syndrome (MDS), suggesting that spliceosomal dysfunction plays a major role in disease pathogenesis. The aberrantly spliced target genes and deregulated cellular pathways asso...
Үндсэн зохиолчид: | Pellagatti, A, Boultwood, J |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
Elsevier
2016
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Splicing factor mutations in the myelodysplastic syndromes: target genes and therapeutic approaches
-н: Armstrong, R, зэрэг
Хэвлэсэн: (2017) -
The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.
-н: Boultwood, J, зэрэг
Хэвлэсэн: (2014) -
Identification of aberrant splicing events in myelodysplastic syndrome patients with splicing factor gene mutations
-н: Pellagatti, A, зэрэг
Хэвлэсэн: (2017) -
Gene expression profiling in the myelodysplastic syndromes.
-н: Pellagatti, A, зэрэг
Хэвлэсэн: (2005) -
Replication stress signaling is a therapeutic target in myelodysplastic syndromes with splicing factor mutations
-н: Johanna Flach, зэрэг
Хэвлэсэн: (2020-09-01)